Both in Pharmaceuticals
Corvus Pharmaceuticals vs Ardelyx
Over the past year CRVS returned +30.6% and ARDX returned −48.8%; their daily moves had a correlation of 0.35.
CRVS +30.6% ARDX −48.8%Growth of $1, one year, split-adjusted
| Metric | CRVS | ARDX |
|---|---|---|
| Price | $10.03 | $3.03 |
| Market cap | $843.7M | $782.3M |
| Today | −1.96% | −2.26% |
| 1 month | −8.2% | −10.4% |
| 6 months | −35.1% | −56.0% |
| Year to date | +30.3% | −48.0% |
| 1 year | +30.6% | −38.9% |
| Revenue growth (YoY) | — | +23.8% |
| Gross margin | — | 95.2% |
| Net margin | — | −13.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.7× |
| Net cash | $215.2M | $30.0M |
| Dividend yield | — | — |
| Volatility (60d) | 51.7% | 51.9% |
| Short % of float | 25.5% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).